Supernus Pharmaceuticals | SUPN - 资产

股票价格

49.43

每天变化

-1.77 -3.46%

每月一次

0.43%

每年

47.86%

Q2 预测

48.44

金融业

USD

USD 1.5B

现金及等价物

USD 184.87M

USD 49.04M

USD 731.58M

USD 373.93M

USD 40.98M

USD -35.25M

USD 29.23M

674

EPS每股收益

USD 0.6

股本和储备

USD 1.08B

USD 129.36M

债务利息支出

USD 910K

USD 2.02M

USD 400.38M

USD 2.8B

USD -2.29M

USD 1.08B

USD -35.25M

普通股股本

USD 58.04M

44.21

USD -5.95M

USD 207.71M

销售和管理费用

USD 118.23M

USD 110.77M

贸易债权人

USD 10.17M

应收帐款人

USD 182.18M

	资产	更改		日
Abbott	USD 110.43B		23.72B	2026-03
ANI Pharmaceuticals	USD 1.42B		18.41M	2026-03
Aurora Cannabis	CAD 775.29M		18.43M	2025-12
Bristol-Myers Squibb	USD 86.48B		3.56B	2026-03
Canopy Growth	CAD 1.11B		36.35M	2025-12
Cara Therapeutics	USD 32.07M		6.95M	2025-12
Corcept Therapeutics	USD 814.88M		21.77M	2026-03
Eisai	JPY 1.49T		48.22B	2025-12
Eli Lilly	USD 116.58B		4.1B	2026-03
Novo Nordisk	DKK 559.22B		16.32B	2026-03
Pacira	USD 1.21B		56.38M	2026-03
Perrigo	USD 7.98B		551.9M	2026-03
Pfizer	USD 207.62B		542M	2026-03
Supernus Pharmaceuticals	USD 1.5B		48.08M	2026-03
United Therapeutics	USD 6.71B		1.17B	2026-03
Xeris Pharmaceuticals	USD 392.01M		8.49M	2026-03